IOL Chemicals and Pharmaceuticals Limited — Others, 22-08-2025: Shareholders meeting

IOL Chemicals and Pharmaceuticals' 38th Annual General Meeting saw shareholders approve all five proposed resolutions. Key approvals included adopting the company's standalone and consolidated audited financial statements for the financial year ended March 31, 2025. Shareholders also re-approved the appointments of Mr. Abhiraj Gupta as a director and Mr. Vikas Gupta as Joint Managing Director for five years. Additionally, the appointment of B.K. Gupta & Associates as Secretarial Auditor for a five-year term and the remuneration for the Cost Auditor for the financial year ending March 31, 2026, received shareholder assent. This confirms stable governance and financial oversight.